Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive

E. Zanotti, R. Corsico, C. Rampulla, N. Ambrosino, C. Fracchia, P. Crotti, F. Rubini, S. Nava

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

It has been shown that chronic oral steroid therapy (ST) does not induce respiratory muscle dysfunction in normal and asthmatic subjects. As corticosteroids are sometimes chronically used in the treatment of the patients with chronic obstructive pulmonary disease (COPD), the aim of our study was to verify whether ST could cause respiratory muscle impairment and, since ST also affects the central nervous system, whether ST could influence the ventilatory pattern. We retrospectively studied 12 COPD patients (group A), on long-term therapy (for at least 4 consecutive months, range 4-18 months) with an oral steroid, deflazacort, 15 mg·d-1. The subjects were strictly matched, with regard to age, sex, height, weight, forced expiratory volume in one second (FEV1), residual volume (RV), arterial oxygen tension (PaCO2), arterial carbon dioxide tension (PaCO2) and pH, with 12 COPD patients (Group B) who had never taken oral steroids. To assess respiratory muscle strength, we measured maximal inspiratory (MIP) and expiratory (MEP) pressures, while mouth occlusion pressure (P0.1) was employed to assess neuromuscular drive; ventilatory pattern and airway impedence were also evaluated. Effectiveness of ST was confirmed by the plasmatic levels of endogenous cortisol. No significant differences were observed between the two groups with regard to MIP (A 72.2 ± 9.7 vs B: 70 ± 7.2 cmH2O) and MEP (A 91.6 ± 10.5 vs B 94.4 ± 7.6 cmH2O) whilst P0.1 was significantly higher in group A (2.6 ± 0.3 cmH2O) than in group B (1.8 ± 0.1 cmH2O). No significant differences were found among all the ventilatory parameters, but the impedence was significantly higher in group A. Chronic administration of oral steroids in COPD patients, at relatively low doses, does not affect respiratory muscle strength, whilst increasing the neuromuscular drive.

Original languageEnglish
Pages (from-to)16-22
Number of pages7
JournalMonaldi Archives for Chest Disease - Cardiac Series
Volume48
Issue number1
Publication statusPublished - 1993

Fingerprint

Respiratory Muscles
Steroids
Chronic Obstructive Pulmonary Disease
Muscle Strength
Therapeutics
Residual Volume
Forced Expiratory Volume
Carbon Dioxide
Oral Administration
Mouth
Hydrocortisone
Arterial Pressure
Adrenal Cortex Hormones
Central Nervous System
Oxygen
Pressure
Weights and Measures

Keywords

  • airway impedance
  • airway occlusion pressure
  • corticosteroids
  • maximal expiratory pressure
  • maximal inspiratory pressure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine

Cite this

Zanotti, E., Corsico, R., Rampulla, C., Ambrosino, N., Fracchia, C., Crotti, P., ... Nava, S. (1993). Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive. Monaldi Archives for Chest Disease - Cardiac Series, 48(1), 16-22.

Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive. / Zanotti, E.; Corsico, R.; Rampulla, C.; Ambrosino, N.; Fracchia, C.; Crotti, P.; Rubini, F.; Nava, S.

In: Monaldi Archives for Chest Disease - Cardiac Series, Vol. 48, No. 1, 1993, p. 16-22.

Research output: Contribution to journalArticle

Zanotti, E, Corsico, R, Rampulla, C, Ambrosino, N, Fracchia, C, Crotti, P, Rubini, F & Nava, S 1993, 'Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive', Monaldi Archives for Chest Disease - Cardiac Series, vol. 48, no. 1, pp. 16-22.
Zanotti, E. ; Corsico, R. ; Rampulla, C. ; Ambrosino, N. ; Fracchia, C. ; Crotti, P. ; Rubini, F. ; Nava, S. / Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive. In: Monaldi Archives for Chest Disease - Cardiac Series. 1993 ; Vol. 48, No. 1. pp. 16-22.
@article{cdc38c9d8c624583857c026ff6a745e6,
title = "Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive",
abstract = "It has been shown that chronic oral steroid therapy (ST) does not induce respiratory muscle dysfunction in normal and asthmatic subjects. As corticosteroids are sometimes chronically used in the treatment of the patients with chronic obstructive pulmonary disease (COPD), the aim of our study was to verify whether ST could cause respiratory muscle impairment and, since ST also affects the central nervous system, whether ST could influence the ventilatory pattern. We retrospectively studied 12 COPD patients (group A), on long-term therapy (for at least 4 consecutive months, range 4-18 months) with an oral steroid, deflazacort, 15 mg·d-1. The subjects were strictly matched, with regard to age, sex, height, weight, forced expiratory volume in one second (FEV1), residual volume (RV), arterial oxygen tension (PaCO2), arterial carbon dioxide tension (PaCO2) and pH, with 12 COPD patients (Group B) who had never taken oral steroids. To assess respiratory muscle strength, we measured maximal inspiratory (MIP) and expiratory (MEP) pressures, while mouth occlusion pressure (P0.1) was employed to assess neuromuscular drive; ventilatory pattern and airway impedence were also evaluated. Effectiveness of ST was confirmed by the plasmatic levels of endogenous cortisol. No significant differences were observed between the two groups with regard to MIP (A 72.2 ± 9.7 vs B: 70 ± 7.2 cmH2O) and MEP (A 91.6 ± 10.5 vs B 94.4 ± 7.6 cmH2O) whilst P0.1 was significantly higher in group A (2.6 ± 0.3 cmH2O) than in group B (1.8 ± 0.1 cmH2O). No significant differences were found among all the ventilatory parameters, but the impedence was significantly higher in group A. Chronic administration of oral steroids in COPD patients, at relatively low doses, does not affect respiratory muscle strength, whilst increasing the neuromuscular drive.",
keywords = "airway impedance, airway occlusion pressure, corticosteroids, maximal expiratory pressure, maximal inspiratory pressure",
author = "E. Zanotti and R. Corsico and C. Rampulla and N. Ambrosino and C. Fracchia and P. Crotti and F. Rubini and S. Nava",
year = "1993",
language = "English",
volume = "48",
pages = "16--22",
journal = "Monaldi Archives for Chest Disease",
issn = "1122-0643",
publisher = "Fondazione Salvatore Maugeri",
number = "1",

}

TY - JOUR

T1 - Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive

AU - Zanotti, E.

AU - Corsico, R.

AU - Rampulla, C.

AU - Ambrosino, N.

AU - Fracchia, C.

AU - Crotti, P.

AU - Rubini, F.

AU - Nava, S.

PY - 1993

Y1 - 1993

N2 - It has been shown that chronic oral steroid therapy (ST) does not induce respiratory muscle dysfunction in normal and asthmatic subjects. As corticosteroids are sometimes chronically used in the treatment of the patients with chronic obstructive pulmonary disease (COPD), the aim of our study was to verify whether ST could cause respiratory muscle impairment and, since ST also affects the central nervous system, whether ST could influence the ventilatory pattern. We retrospectively studied 12 COPD patients (group A), on long-term therapy (for at least 4 consecutive months, range 4-18 months) with an oral steroid, deflazacort, 15 mg·d-1. The subjects were strictly matched, with regard to age, sex, height, weight, forced expiratory volume in one second (FEV1), residual volume (RV), arterial oxygen tension (PaCO2), arterial carbon dioxide tension (PaCO2) and pH, with 12 COPD patients (Group B) who had never taken oral steroids. To assess respiratory muscle strength, we measured maximal inspiratory (MIP) and expiratory (MEP) pressures, while mouth occlusion pressure (P0.1) was employed to assess neuromuscular drive; ventilatory pattern and airway impedence were also evaluated. Effectiveness of ST was confirmed by the plasmatic levels of endogenous cortisol. No significant differences were observed between the two groups with regard to MIP (A 72.2 ± 9.7 vs B: 70 ± 7.2 cmH2O) and MEP (A 91.6 ± 10.5 vs B 94.4 ± 7.6 cmH2O) whilst P0.1 was significantly higher in group A (2.6 ± 0.3 cmH2O) than in group B (1.8 ± 0.1 cmH2O). No significant differences were found among all the ventilatory parameters, but the impedence was significantly higher in group A. Chronic administration of oral steroids in COPD patients, at relatively low doses, does not affect respiratory muscle strength, whilst increasing the neuromuscular drive.

AB - It has been shown that chronic oral steroid therapy (ST) does not induce respiratory muscle dysfunction in normal and asthmatic subjects. As corticosteroids are sometimes chronically used in the treatment of the patients with chronic obstructive pulmonary disease (COPD), the aim of our study was to verify whether ST could cause respiratory muscle impairment and, since ST also affects the central nervous system, whether ST could influence the ventilatory pattern. We retrospectively studied 12 COPD patients (group A), on long-term therapy (for at least 4 consecutive months, range 4-18 months) with an oral steroid, deflazacort, 15 mg·d-1. The subjects were strictly matched, with regard to age, sex, height, weight, forced expiratory volume in one second (FEV1), residual volume (RV), arterial oxygen tension (PaCO2), arterial carbon dioxide tension (PaCO2) and pH, with 12 COPD patients (Group B) who had never taken oral steroids. To assess respiratory muscle strength, we measured maximal inspiratory (MIP) and expiratory (MEP) pressures, while mouth occlusion pressure (P0.1) was employed to assess neuromuscular drive; ventilatory pattern and airway impedence were also evaluated. Effectiveness of ST was confirmed by the plasmatic levels of endogenous cortisol. No significant differences were observed between the two groups with regard to MIP (A 72.2 ± 9.7 vs B: 70 ± 7.2 cmH2O) and MEP (A 91.6 ± 10.5 vs B 94.4 ± 7.6 cmH2O) whilst P0.1 was significantly higher in group A (2.6 ± 0.3 cmH2O) than in group B (1.8 ± 0.1 cmH2O). No significant differences were found among all the ventilatory parameters, but the impedence was significantly higher in group A. Chronic administration of oral steroids in COPD patients, at relatively low doses, does not affect respiratory muscle strength, whilst increasing the neuromuscular drive.

KW - airway impedance

KW - airway occlusion pressure

KW - corticosteroids

KW - maximal expiratory pressure

KW - maximal inspiratory pressure

UR - http://www.scopus.com/inward/record.url?scp=0027155004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027155004&partnerID=8YFLogxK

M3 - Article

C2 - 8472057

AN - SCOPUS:0027155004

VL - 48

SP - 16

EP - 22

JO - Monaldi Archives for Chest Disease

JF - Monaldi Archives for Chest Disease

SN - 1122-0643

IS - 1

ER -